2008
DOI: 10.1093/jnci/djn253
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes

Abstract: BackgroundLeukemia evolves through a multistep process from premalignancy to malignancy. Epigenetic alterations, including histone modifications, have been proposed to play an important role in tumorigenesis. The involvement of two chromatin remodeling genes, retinoblastoma-binding protein 1 (Rbbp1/Arid4a) and Rbbp1-like 1 (Rbbp1l1/Arid4b), in leukemogenesis was not characterized.MethodsThe leukemic phenotype of mice deficient for Arid4a with or without haploinsufficiency for Arid4b was investigated by seriall… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
60
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(61 citation statements)
references
References 51 publications
1
60
0
Order By: Relevance
“…Retinoblastoma-binding protein 1 (RBBP1) 3 and its homolog RBBP1-like protein 1 (RBBP1L1) are leukemia and tumor suppressors that specifically interact with retinoblastoma protein (RB) and the mSin3A complex to suppress gene repression (1)(2)(3)(4)(5)(6)(7)(8). Peptide sequences, including KASIFLK in RBBP1 (9) and SSKKQKRSHK and IKPSLGSKK in RBBP1L1 (6,10), have been identified as breast carcinoma antigen epitopes.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Retinoblastoma-binding protein 1 (RBBP1) 3 and its homolog RBBP1-like protein 1 (RBBP1L1) are leukemia and tumor suppressors that specifically interact with retinoblastoma protein (RB) and the mSin3A complex to suppress gene repression (1)(2)(3)(4)(5)(6)(7)(8). Peptide sequences, including KASIFLK in RBBP1 (9) and SSKKQKRSHK and IKPSLGSKK in RBBP1L1 (6,10), have been identified as breast carcinoma antigen epitopes.…”
mentioning
confidence: 99%
“…Peptide sequences, including KASIFLK in RBBP1 (9) and SSKKQKRSHK and IKPSLGSKK in RBBP1L1 (6,10), have been identified as breast carcinoma antigen epitopes. RBBP1 and RBBP1L1 regulate epigenetic marks, such as methylation of lysines in histones H3 and H4, which are observed in leukemia and Prader-Willi/Angelman syndromes (2,11). The epigenetic regulation function of RBBP1 was proposed to be mediated by its three Royal Family domains (2,11,12), including the chromobarrel domain, Tudor domain, and Pro-Trp-Trp-Pro (PWWP) domain, but our previous study indicated that of these three domains, only the chromobarrel domain can bind with histone tails and is responsible for the epigenetic regulation function (13).…”
mentioning
confidence: 99%
“…For example, breast cancer metastasis suppressor 1 (BRMS1) can suppress metastasis of cancer in mouse models (18). In addition, ING1 and retinoblastoma binding protein 1 (RBP1) display tumor suppressive properties (19,20). Moreover, some Sin3 complex subunits may display both tumor suppressive and oncogenic properties depending on the context (i.e.…”
mentioning
confidence: 99%
“…2Aa knock down these transcription factors. BRCAA1 is a known tumor suppressor gene, since its deficiency in mice leads to leukemia (32), and mutations in this gene contribute to development of human diseases and cancer through epigenetic mechanisms (32). However, given that the 549-nt AS RNA is embedded in BRCAA1 intronic elements, it is tempting to speculate that one potential mechanism of the tumor suppression mediated by BRCAA1 gene pertains to potential antiproliferative activity of this AS species, which contains NF-Y binding sites.…”
Section: Discussionmentioning
confidence: 99%
“…RNAs were separated on 12% denaturing urea-polyacryamide gels and transferred to a nylon membrane. S and AS ODN probes end labeled with 32 P were used to detect AS and S endogenous U3 RNAs separately. RNAs of four matched pairs of human breast cancer and adjacent normal mammary tissues were obtained from Indivumed.…”
Section: Methodsmentioning
confidence: 99%